Northwest Biotherapeutics (NWBO)

Northwest Biotherapeutics (NWBO) Earnings Date & Reports


Earnings Data

Report Date
May 16, 2018
After Close Confirmed
Period Ending
2018 (Q1)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings


Northwest Biotherapeutics (NWBO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NWBO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
May 16, 20182018 (Q1)
- / -0.09
-0.08-11.25% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

NWBO Earnings-Related Price Changes

No data currently available
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.


When does Northwest Biotherapeutics (NWBO) report earnings?
Northwest Biotherapeutics (NWBO) is schdueled to report earning on May 16, 2018, After Close Confirmed.
    What is Northwest Biotherapeutics (NWBO) earnings time?
    Northwest Biotherapeutics (NWBO) earnings time is at May 16, 2018, After Close Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NWBO EPS forecast?
          Currently, no data Available

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis